A detailed history of Lpl Financial LLC transactions in Novartis Ag stock. As of the latest transaction made, Lpl Financial LLC holds 431,589 shares of NVS stock, worth $42.8 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares
431,589
Previous 402,094 7.34%
Holding current value
$42.8 Million
Previous $42.8 Million 15.97%
% of portfolio
0.02%
Previous 0.02%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 08, 2024

BUY
$106.13 - $120.89 $3.13 Million - $3.57 Million
29,495 Added 7.34%
431,589 $49.6 Million
Q2 2024

Aug 07, 2024

BUY
$92.57 - $107.37 $3.8 Million - $4.41 Million
41,046 Added 11.37%
402,094 $42.8 Million
Q1 2024

May 10, 2024

BUY
$95.27 - $108.47 $1.43 Million - $1.63 Million
15,026 Added 4.34%
361,048 $34.9 Million
Q4 2023

Feb 14, 2024

BUY
$92.27 - $101.54 $1.47 Million - $1.62 Million
15,980 Added 4.84%
346,022 $34.9 Million
Q3 2023

Nov 13, 2023

BUY
$94.73 - $105.13 $427,232 - $474,136
4,510 Added 1.39%
330,042 $33.6 Million
Q2 2023

Jul 31, 2023

BUY
$92.52 - $104.91 $2.42 Million - $2.75 Million
26,185 Added 8.75%
325,532 $32.8 Million
Q1 2023

May 10, 2023

SELL
$80.03 - $92.81 $1.76 Million - $2.04 Million
-22,026 Reduced 6.85%
299,347 $27.5 Million
Q4 2022

Feb 07, 2023

BUY
$75.55 - $92.52 $805,287 - $986,170
10,659 Added 3.43%
321,373 $29.2 Million
Q3 2022

Nov 14, 2022

SELL
$74.61 - $87.26 $1.05 Million - $1.23 Million
-14,106 Reduced 4.34%
310,714 $23.6 Million
Q2 2022

Aug 12, 2022

BUY
$80.52 - $93.75 $3.68 Million - $4.28 Million
45,658 Added 16.36%
324,820 $27.5 Million
Q1 2022

May 16, 2022

BUY
$80.11 - $90.62 $2.29 Million - $2.6 Million
28,646 Added 11.43%
279,162 $24.5 Million
Q4 2021

Feb 14, 2022

SELL
$79.7 - $88.13 $1.25 Million - $1.38 Million
-15,634 Reduced 5.87%
250,516 $21.9 Million
Q3 2021

Nov 15, 2021

BUY
$81.78 - $95.14 $165,768 - $192,848
2,027 Added 0.77%
266,150 $21.8 Million
Q2 2021

Aug 13, 2021

SELL
$85.24 - $94.15 $291,861 - $322,369
-3,424 Reduced 1.28%
264,123 $24.1 Million
Q1 2021

May 14, 2021

SELL
$83.5 - $98.47 $409,066 - $482,404
-4,899 Reduced 1.8%
267,547 $22.9 Million
Q4 2020

Feb 12, 2021

BUY
$78.07 - $94.43 $4.45 Million - $5.39 Million
57,043 Added 26.48%
272,446 $25.7 Million
Q3 2020

Nov 09, 2020

SELL
$82.14 - $91.0 $365,851 - $405,314
-4,454 Reduced 2.03%
215,403 $18.7 Million
Q2 2020

Aug 13, 2020

BUY
$80.93 - $91.1 $1.04 Million - $1.17 Million
12,878 Added 6.22%
219,857 $19.2 Million
Q1 2020

May 14, 2020

BUY
$70.67 - $99.01 $756,027 - $1.06 Million
10,698 Added 5.45%
206,979 $17.1 Million
Q4 2019

Feb 14, 2020

BUY
$84.35 - $95.37 $821,315 - $928,617
9,737 Added 5.22%
196,281 $18.6 Million
Q3 2019

Nov 13, 2019

BUY
$85.54 - $94.26 $1.32 Million - $1.45 Million
15,400 Added 9.0%
186,544 $16.2 Million
Q2 2019

Aug 09, 2019

BUY
$75.4 - $92.8 $1.65 Million - $2.04 Million
21,943 Added 14.71%
171,144 $15.6 Million
Q1 2019

May 08, 2019

BUY
$75.32 - $86.15 $780,390 - $892,600
10,361 Added 7.46%
149,201 $14.3 Million
Q4 2018

Feb 07, 2019

BUY
$73.66 - $82.02 $531,309 - $591,610
7,213 Added 5.48%
138,840 $11.9 Million
Q3 2018

Nov 14, 2018

BUY
$66.94 - $77.43 $709,430 - $820,603
10,598 Added 8.76%
131,627 $11.3 Million
Q2 2018

Aug 14, 2018

BUY
$64.91 - $73.36 $697,782 - $788,620
10,750 Added 9.75%
121,029 $9.14 Million
Q1 2018

May 15, 2018

BUY
$70.39 - $84.15 $923,939 - $1.1 Million
13,126 Added 13.51%
110,279 $8.92 Million
Q4 2017

Feb 14, 2018

BUY
$72.33 - $77.64 $572,781 - $614,831
7,919 Added 8.87%
97,153 $8.16 Million
Q3 2017

Nov 14, 2017

BUY
$74.14 - $77.27 $812,945 - $847,265
10,965 Added 14.01%
89,234 $7.66 Million
Q2 2017

Aug 14, 2017

BUY
N/A
78,269
78,269 $6.53 Million

Others Institutions Holding NVS

About NOVARTIS AG


  • Ticker NVS
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,151,000,064
  • Market Cap $213B
  • Description
  • Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...
More about NVS
Track This Portfolio

Track Lpl Financial LLC Portfolio

Follow Lpl Financial LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Lpl Financial LLC, based on Form 13F filings with the SEC.

News

Stay updated on Lpl Financial LLC with notifications on news.